N (%) | DA1 | Delivery2 | Indication | Diagnosis | HDs3 |
---|---|---|---|---|---|
Within 24 hours | |||||
Misoprostol†5 (6.3%) | 01 | VVD | Rule out infection | Elevated CRP4WBC5 | 07 |
 | 01 | VVD | Respiratory distress | Respiratory infection | 11 |
 | 01 | CS | Rule out asphyxia | Infection | 10 |
 | 01 | SVD | Respiratory distress | Work up for infection | 03 |
 | 01 | VVD | Respiratory distress | Work up for infection | 04 |
Dinoprostone†3 (3.6%) | 01 | VVD | Respiratory distress | Atelectasis | 06 |
 | 01 | SVD | Rule out asphyxia | Infection | 10 |
 | 01 | SVD | Respiratory distress | Respiratory infection | 10 |
After 24 hours | |||||
Misoprostol†6 (7.2%) | 02 | VVD | Rule out infection | WBC in CSF6 | 10 |
 | 07 | VVD | Hyperbilirubinemia | Urinary infection | 07 |
 | 04 | SVD | Hyperbilirubinemia | Icterus | 04 |
 | 08 | SVD | Infection | Respiratory infection | 10 |
 | 03 | SVD | Feeding difficulty | WBC in CSF | 20 |
 | 05 | CS | Hyperbilirubinemia | Icterus | 04 |
Dinoprostone†1 (1.2%) | 17 | SVD | Fever | WBC in CSF | 15 |